For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Applications
USP Abacavir and Lamivudine Tablets - Assay (Standard Solution)
28077
Separation Mode: Reversed Phase
Reversed Phase
C18
HPLC
Anti-HIV Agents
Pharmaceutical
Pharmaceutical
Therapeutic / Clinical

USP Abacavir and Lamivudine Tablets - Assay (Standard Solution)

Analytes
1Lamivudine
2Abacavir
Details
LC Conditions (App ID: 28077)
Column:
Brand Name:
Luna Omega
Part No:
Phase Name:
C18
System:
Agilent Technologies 1200 Series Agilent Technologies 1200 Series
Sample Note:
0.35 mg/mL of USP Abacavir Sulfate RS and 0.15 mg/mL of USP Lamivudine RS in 0.1N hydrochloric acid. Sonicate to dissolve prior to final dilution. Pass through a Nylon filter (Clarify Syringe filter PN: AF8-7707-12)
Similar Applications
search
No Data